| 1 | 6TW0 |
5'-nucleotidase | Homo sapiens |
P21589 (5NTD_HUMAN) |
[[(2~{R},3~{S},4~{R},5~{R})-5-(6-azanyl-2-oxidanylidene-3~{H}-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]methylphosphonic acid |
NYZ |
 |
SHOW |
| 2 | 4O9V |
Suppressor of tumorigenicity 14 protein | Homo sapiens |
Q9Y5Y6 (ST14_HUMAN) |
N-(trans-4-aminocyclohexyl)-3,5-bis(4-carbamimidoylphenoxy)benzamide |
NT4 |
 |
SHOW |
| 3 | 4IU1 |
Arginase | Leishmania mexicana |
Q6TUJ5 (Q6TUJ5_LEIME) |
NOR-N-OMEGA-HYDROXY-L-ARGININE |
NNH |
 |
SHOW |
| 4 | 3KV2 |
Arginase-1 | Homo sapiens |
P05089 (ARGI1_HUMAN) |
NOR-N-OMEGA-HYDROXY-L-ARGININE |
NNH |
|
SHOW |
| 5 | 4C5W |
Gamma-butyrobetaine dioxygenase | Homo sapiens |
O75936 (BODG_HUMAN) |
ethyl-dimethyl-(4-oxidanyl-4-oxidanylidene-butyl)azanium |
NM3 |
 |
SHOW |
| 6 | 2WSX |
L-carnitine/gamma-butyrobetaine antiporter | Escherichia coli |
P31553 (CAIT_ECOLI) |
3-CARBOXY-N,N,N-TRIMETHYLPROPAN-1-AMINIUM |
NM2 |
 |
SHOW |
| 7 | 3O2G |
Gamma-butyrobetaine dioxygenase | Homo sapiens |
O75936 (BODG_HUMAN) |
3-CARBOXY-N,N,N-TRIMETHYLPROPAN-1-AMINIUM |
NM2 |
|
SHOW |
| 8 | 3OB9 |
Male-specific lethal 3 homolog | Homo sapiens |
Q8N5Y2 (MS3L1_HUMAN) |
2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID |
NHE |
 |
SHOW |
| 9 | 4H75 |
Spindlin-1 | Homo sapiens |
Q9Y657 (SPIN1_HUMAN) |
2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID |
NHE |
|
SHOW |
| 10 | 6K35 |
Beta-N-acetylhexosaminidase | Vibrio harveyi |
D9ISE0 (D9ISE0_VIBHA) |
3AR,5R,6S,7R,7AR-5-HYDROXYMETHYL-2-METHYL-5,6,7,7A-TETRAHYDRO-3AH-PYRANO[3,2-D]THIAZOLE-6,7-DIOL |
NGT |
 |
SHOW |
| 11 | 3IX1 |
Formylaminopyrimidine-binding protein | Bacillus halodurans |
Q9K9G5 (THIY_BACHD) |
N-[(4-amino-2-methylpyrimidin-5-yl)methyl]formamide |
NFM |
 |
SHOW |
| 12 | 3WMC |
Beta-hexosaminidase | Ostrinia furnacalis |
Q06GJ0 (Q06GJ0_OSTFU) |
6-(dimethylamino)-2-(2-{[(5-methyl-1,3,4-thiadiazol-2-yl)methyl]amino}ethyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione |
NF6 |
 |
SHOW |
| 13 | 3WMB |
Beta-hexosaminidase | Ostrinia furnacalis |
Q06GJ0 (Q06GJ0_OSTFU) |
2-(2-{[(5-methyl-1,3,4-thiadiazol-2-yl)methyl]amino}ethyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione |
NF1 |
 |
SHOW |
| 14 | 3IJC |
Polycomb protein EED | Homo sapiens |
O75530 (EED_HUMAN) |
ETHYL DIMETHYL AMMONIO PROPANE SULFONATE |
NDS |
 |
SHOW |
| 15 | 1JSZ |
Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase | Vaccinia virus |
P07617 (MCE_VACCW) |
7,9-DIMETHYLGUANINE |
NDM |
 |
SHOW |
| 16 | 1UW6 |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
(S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE |
NCT |
 |
SHOW |
| 17 | 6CNK |
Neuronal acetylcholine receptor subunit alpha4beta-2 | Homo sapiens |
P17787 (ACHB2_HUMAN) |
(S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE |
NCT |
|
SHOW |
| 18 | 2YK1 |
Fab fragment heavy chain | Homo sapiens |
- |
(S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE |
NCT |
|
SHOW |
| 19 | 6CNJ |
Neuronal acetylcholine receptor subunit alpha4beta-2 | Homo sapiens |
P17787 (ACHB2_HUMAN) |
(S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE |
NCT |
|
SHOW |
| 20 | 5O87 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
(S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE |
NCT |
|
SHOW |
| 21 | 6C71 |
Amine oxidase | Pseudomonas putida |
F8G0P2 (F8G0P2_PSEP6) |
(S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE |
NCT |
|
SHOW |
| 22 | 5KXI |
Neuronal acetylcholine receptor subunit alpha4beta-2 | Homo sapiens |
P17787 (ACHB2_HUMAN) |
(S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE |
NCT |
|
SHOW |
| 23 | 6PV7 |
Neuronal acetylcholine receptor subunit alpha-3 | Homo sapiens |
P32297 (ACHA3_HUMAN) |
(S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE |
NCT |
|
SHOW |
| 24 | 1DL7 |
Ig lambda-1 chain V regions MOPC 104E/RPC20/J558/S104 | Mus musculus |
P01724 (LV1B_MOUSE) |
P-NITROPHENYL-PHOSPHOCHOLINE |
NCH |
 |
SHOW |
| 25 | 5FTG |
Choline kinase alpha | Homo sapiens |
P35790 (CHKA_HUMAN) |
1-[[4-[2-[4-[[4-(dimethylamino)pyridin-1-yl]methyl]phenoxy]ethoxy]phenyl]methyl]-N,N-dimethyl-pyridin-4-amine |
NBR |
 |
SHOW |